Novo Nordisk CEO: By 2030 We Will Have Manufacturing That Will Be Able To Cater To 5 Million Patients On The Wegovy Pill
Novo Nordisk CEO: By 2030 We Will Have Manufacturing That Will Be Able To Cater To 5 Million Patients On The Wegovy Pill
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Novo Nordisk CEO: By 2030 We Will Have Manufacturing That Will Be Able To Cater To 5 Million Patients On The Wegovy Pill